SRP
NVO

Saddle Road Partners’s Novo Nordisk NVO Stock Holding History

Saddle Road Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$359K Hold
20,000
– – 0.18% 93
2016
Q3 		$416K Hold
20,000
– – 0.24% 92
2016
Q2 		$538K Hold
20,000
– – 0.32% 74
2016
Q1 		$542K Hold
20,000
– – 0.34% 80
2015
Q4 		$581K Buy
+20,000
New +$554K 0.4% 67

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Saddle Road Partners's NVO Position: Q4 2016 in Review

Saddle Road Partners held its Novo Nordisk (NVO) position steady in Q4 2016 at 20,000 shares worth $359K. The position accounts for 0.18% of the portfolio, ranked #93.

Saddle Road Partners first reported a position in NVO in Q4 2015 and has held it in 5 quarters since. The position peaked at $581K in Q4 2015. 482 funds tracked by Wall St. Rank hold NVO as of Q4 2016.

  • Saddle Road Partners held 20,000 shares of Novo Nordisk worth $359K as of Q4 2016.
  • Saddle Road Partners left its Novo Nordisk share count unchanged in Q4 2016.
  • Novo Nordisk made up 0.18% of Saddle Road Partners's portfolio in Q4 2016, its #93 holding.
  • Saddle Road Partners first reported a position in Novo Nordisk in Q4 2015 and has held it in 5 quarters since.
  • Saddle Road Partners's Novo Nordisk position peaked at $581K in Q4 2015.
  • 482 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2016.

Based on Saddle Road Partners's 13F filing for Q4 2016, filed 6 Jan 2017.